Prodrugs and Targeted Delivery: Towards Better ADME Properties (Methods & Principles in Medicinal Chemistry). Este artículo no está disponible.
Idioma: inglés
Editorial: Wiley-VCH, 2011
- Tapa dura
- Nuevo

Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections
Vendedor de 5 estrellas
Vendedor de IberLibro desde 25 de marzo de 2015
No disponible
Tapa dura
Condición: Nuevo
EUR 195,52
Descripción del artículo del vendedor
In English.
N° de ref. del artículo ria9783527326037_new
- Título
- Prodrugs and Targeted Delivery: Towards Better ADME Properties (Methods & Principles in Medicinal Chemistry)
- Editorial
- Wiley-VCH
- Año de publicación
- 2011
- Estado
- New
- Encuadernación
- Encuadernación de tapa dura
- Idioma
- inglés
- ISBN 10
- 3527326030
- ISBN 13
- 9783527326037
- Peso del artículo
- 1224 gramos
This topical reference and handbook addresses the chemistry, pharmacology, toxicology and the patentability of prodrugs, perfectly mirroring the integrated approach prevalent in today's drug design. It summarizes current experiences and strategies for the rational design of prodrugs, beginning at the early stages of the development process, as well as discussing organ- and site-selective prodrugs.
Every company employing medicinal chemists will be interested in this practice-oriented overview of a key strategy in modern drug discovery and development.
Every company employing medicinal chemists will be interested in this practice-oriented overview of a key strategy in modern drug discovery and development.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Jarkko Rautio is professor of pharmaceutical chemistry and head of the multidisciplinary Pharmaceutical and Medicinal Chemistry (PMC) research group at the School of Pharmacy, University of Eastern Finland (formerly University of Kuopio), where he received his PhD in pharmaceutical chemistry in 2000. He subsequently carried out his postdoctoral studies at the University of Maryland, Baltimore, USA, and was a visiting scientist at GlaxoSmithKline, North Carolina, while also co-founding the American Association of Pharmaceutical Scientists (AAPS) Prodrug Focus Group in 2005. Professor Rautio's research focuses on chemistry-based methods, especially prodrugs, to overcome the liabilities of drugs.
“Acerca de” puede pertenecer a otra edición de este título.